INDP
Indaptus Therapeutics, Inc. - Common Stock (INDP)
$80
About Indaptus Therapeutics, Inc. - Common Stock (INDP)
Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Details
Daily high
$1.90
Daily low
$1.52
Price at open
$1.52
52 Week High
$47.60
52 Week Low
$1.52
Market cap
3.5M
Dividend yield
0.00%
Volume
49,267
Avg. volume
75,161
P/E ratio
-.05
Indaptus Therapeutics, Inc. - Common Stock News
Details
Daily high
$1.90
Daily low
$1.52
Price at open
$1.52
52 Week High
$47.60
52 Week Low
$1.52
Market cap
3.5M
Dividend yield
0.00%
Volume
49,267
Avg. volume
75,161
P/E ratio
-.05